相关实验视频

Updated: May 29, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

一个比较的,多中心的,前性的,随机的研究,以评估胺基后生物保湿剂与氨酸基保湿剂在轻度至中度无皮炎的疗效,安全性和复发延迟

Abhishek De¹, Saswati Halder², Amit Madan³

¹Dermatology, Wizderm Speciality Skin and Hair Clinic, Kolkata, IND.

|February 3, 2025

概括

基于陶胺的后生物性保湿剂显著延长了阿托皮性皮炎 (AD) 患者的缓解期,而不是基于的选择. 这一发现突出了其在治疗慢性炎症性皮肤疾病方面的潜力.

科学领域:

皮肤病学皮肤病学
免疫学免疫学免疫学
生物技术是生物技术.

背景情况:

亚托皮炎 (AD) 是一种慢性炎症性皮肤疾病,其特点是皮肤屏障功能受损和免疫失调.
在AD管理中,保湿剂对于修复皮肤屏障至关重要.
艾滋病患者及其家属的生活质量受到重大影响.

研究的目的:

在轻度至中度的AD中,比较基于陶胺的后生物保湿剂与基于石的保湿剂的疗效,安全性和复发预防.
评估不同保湿剂对疾病缓解的长期影响.

主要方法:

160名阿尔茨海默病患者被分为两组,接受基于胺的后生物保湿剂或基于胺的保湿剂以及0.05%的desonide奶油四周.
患者完全恢复后进入维持阶段,持续长达三个月,每隔两周进行一次随访.
监测复发时间和缓解期.

主要成果:

所有患者在四周的治疗后实现了完全的症状消失.
基于陶胺的后生物性保湿剂组与基于石的组 (47.44±21.49天) 相比,显示了明显更长的平均缓解期 (72.52±15.01天).
预计复发的中位时间在以胺为基础的组 (85天) 与以胺为基础的组 (71天) 相比显著延长. 这两种保湿剂都能很好地容忍.

结论:

虽然这两种保湿剂在治疗阶段有效地消除了AD症状,但基于胺的后生物保湿剂在延长缓解期方面表现出更好的效果.
基于胺的后生物性保湿剂在延长轻度至中度AD患者的无病间隔方面具有统计学上显著的优势.
这项研究支持使用基于陶胺的后生物性保湿剂,以改善阿托皮性皮肤炎的长期管理.

关键词:

亚托邦性皮肤炎的发生.陶化物保湿剂陶化物保湿剂护肤品护肤品护肤品后生物保湿剂后生物保湿剂在广告中复发.在广告中的缓解.

更多相关视频

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

相关概念视频

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Surface Membrane Barriers

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...